These lab-made alternatives were not formulated with recreational use in mind. From the nineties, John W. Huffman plus a staff of fellow chemists at Clemson University produced some of the to start with formulation for synthetic cannabinoid receptor agonists (SCRAs), a relatives of substances that imitate the physiological and psychological impacts